CPHI Online：2024年制药业趋势展望报告：产业合作、市场成熟度与数字化未来（英文版）（60页）.pdf

1、2024 Pharma Trends Outlook:Collaboration,Market Maturity,and Digital FuturesIn Partnershipwith2024 Pharma Trends Outlook:Collaboration,Market Maturity,and Digital Futures 2In PartnershipwithContentsContributorsReferences 2024 Pharma Trends in Focus1.Generative AI and supply chain digitisation2.Consu

2、mer driven packaging innovations3.Mature quality management and control4.Biotech and R&D outsourcing practices:investing and acquiring5.Collaborative sustainability by all,for all6.Making excipients great again7.Pricing,cost,and patients-balancing the pharma trinity8.Evidence-based herbal medicines9

3、.The future of B2B pharma marketing10.Accelerating Alzheimers research11.What 2023 drug approvals mean for 202412.Middle East rising:an emerging market in focus2024 Pharma Trends Outlook:Collaboration,Market Maturity,and Digital Futures 3In PartnershipwithIntroductionKey FindingsThe 2023 CPHI Online

4、 Pharma Trends Report delved into critical issues,from reshoring drug production to manufacturing reimagined through Pharma 4.0,exploring how the industry grappled with challenges like supply chain disruption,security,and escalating drug manufacturing costs.Amidst these hurdles,2023 provided a chanc

5、e for the pharmaceutical supply chain to proactively address issues,marking a shift towards resilience and quality management.Learning from the past,the industry is embracing a proactive mindset,propelling it into a new era of supply chain robustness.Protecting consumers from supply shortages,adulte

6、ration,and counterfeit products remains a top priority for the industry.Cross-industry collaboration for sustainability initiatives,the US FDAs Quality Management Maturity program,and patient-centric packaging designs are leading the pharmaceutical industry into the future.Underpinning these strateg